<DOC>
	<DOCNO>NCT00000234</DOCNO>
	<brief_summary>The purpose study evaluate open buprenorphine dose dose choice open exposure .</brief_summary>
	<brief_title>Alternate Day Buprenorphine Administration , Phase XI - 16</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>December 2002</verification_date>
</DOC>